American vaccine group Novavax has begun its phase 2 clinical trials in South Africa this week, this trial is supported in part by a $15 million grant from the Bill & Melinda Gates Foundation and will be led by Dr. Shabir Madhi, Professor of Vaccinology at Wits University. Dr. Shabir Madhi joins CNBC Africa for more.